An antibody-based drug triggers rare inflammatory eye problems in macular degeneration patients

by

A drug approved in 2019 for macular degeneration apparently caused rare retinal side effects because of its interactions with the human immune system, two new studies have concluded.

Leave A Comment

Your email address will not be published. Required fields are marked *